Ultra DFA Respiratory Virus screening & identification kits, IFA Enterovirus reagents, Metapneumovirus reagents, and HSY DFA reagents

NAMRU-6 Virology and Emerging Infections Department (VEID) in Lima Peru, has a requirement for Ultra DFA Respiratory Virus screening & identification kits, IFA Enterovirus reagents, Metapneumovirus reagents, and HSY DFA reagents meet our study protocol requirements. Place of Delivery: NAMRU-6 - Lima Peru - Airport FOB If capable sources are not identified through this notice, then NAMRU 6 intends to award a sole source contract under the authority of FAR 13.106-1(b)(i) to Quidel Corporation for the requirement of NAMRU-6. NAMRU-6 has been using these specific identification kit for more than 10 years already, and our laboratory results have always been accurate, matching or confirming those obtained through these virus identification panels. Quidel Corporation is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people through the development of diagnostic solutions that can lead to improved patient outcomes. The core competences developed at the Quidel Hybridoma facility and capabilities include high-quality antibodies, direct fluorescent antibody panel for influenza A, influenza B, respiratory syncytial virus (RSV), adenovirus, parainfluenza I, parainfluenza 2 and parainfluenza 3 virus by virus isolation. These panels improve laboratory workflow with rapid, sensitive and specific screening and definitive identification for respiratory viruses. Quidel Corporation guarantees the temperature-handling and provide the items with the proper expiration dates that must match with the protocols and surveillance timing. This pre-solicitation is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. Capability statements are due by 12:00 PM Local Time, April 21, 2018. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: ana.c.salinas.fn@mail.mil Please use subject line "N44852__VEID180313".